Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603

Watchlist Manager
Shijiazhuang Yiling Pharmaceutical Co Ltd Logo
Shijiazhuang Yiling Pharmaceutical Co Ltd
SZSE:002603
Watchlist
Price: 16.83 CNY -3.99% Market Closed
Market Cap: 28.1B CNY
Have any thoughts about
Shijiazhuang Yiling Pharmaceutical Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

85
Current
20.6
Median
16.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
85
=
Enterprise Value
28.7B CNY
/
EBIT
337.3m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
16.2
2-Years Forward
EV/EBIT
13.9
3-Years Forward
EV/EBIT
11.9

See Also

Discover More